SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Feb-24 5:02 PM View: | Feris International Inc. (CRVO) | 26-Feb-24 | Sale | 36 | -- | -- | (< 1%) 1.06M to 1.06M | |
28-Feb-24 5:02 PM View: | Feris International Inc. (CRVO) | 26-Feb-24 | Exercise (in-the money or at-the-money) | 495,995 | -- | -- | 88% 561.3K to 1.06M | |
09-Jun-17 4:31 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Jun-17 | Option Exercise | 2,941 | -- | -- | < 1% 358.96K to 361.9K | |
05-Jun-17 5:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Grant | 2,188 | -- | -- | < 1% 359.71K to 361.9K | |
05-Jun-17 5:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Disposition | 2,941 | -- | -- | (< 1%) 361.9K to 358.96K | |
13-Jan-17 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Jan-17 | Option Exercise | 8,000 | $36.30 | $290,400.00 | 2% 359.71K to 367.71K | |
13-Jan-17 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Jan-17 | Market Option Sale (Planned) | 8,000 | $82.48 | $659,846.00 | (2%) 367.71K to 359.71K | (112%) |
06-Jan-17 1:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Jan-17 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
06-Jan-17 1:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Jan-17 | Market Option Sale (Planned) | 6,500 | $77.13 | $501,319.00 | (2%) 366.21K to 359.71K | (127%) |
03-Jan-17 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Dec-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
03-Jan-17 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Dec-16 | Market Option Sale (Planned) | 6,500 | $74.33 | $483,113.00 | (2%) 366.21K to 359.71K | (135%) |
22-Dec-16 10:30 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Dec-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
22-Dec-16 10:30 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Dec-16 | Market Option Sale (Planned) | 6,500 | $74.16 | $482,025.00 | (2%) 366.21K to 359.71K | (136%) |
16-Dec-16 3:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Dec-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
16-Dec-16 3:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Dec-16 | Market Option Sale (Planned) | 6,500 | $77.52 | $503,870.00 | (2%) 366.21K to 359.71K | (125%) |
09-Dec-16 2:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Dec-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
09-Dec-16 2:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Dec-16 | Market Option Sale (Planned) | 6,500 | $75.15 | $488,482.00 | (2%) 366.21K to 359.71K | (133%) |
02-Dec-16 2:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Nov-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
02-Dec-16 2:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Nov-16 | Market Option Sale (Planned) | 6,500 | $83.48 | $542,614.00 | (2%) 366.21K to 359.71K | (109%) |
28-Nov-16 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Nov-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
28-Nov-16 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Nov-16 | Market Option Sale (Planned) | 6,500 | $86.47 | $562,043.00 | (2%) 366.21K to 359.71K | (102%) |
17-Nov-16 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Nov-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
17-Nov-16 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Nov-16 | Market Option Sale (Planned) | 6,500 | $91.55 | $595,058.00 | (2%) 366.21K to 359.71K | (91%) |
14-Nov-16 8:41 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Nov-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
14-Nov-16 8:41 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Nov-16 | Market Option Sale (Planned) | 6,500 | $90.98 | $591,372.00 | (2%) 366.21K to 359.71K | (92%) |
04-Nov-16 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Nov-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
04-Nov-16 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Nov-16 | Market Option Sale (Planned) | 6,500 | $77.75 | $505,400.00 | (2%) 366.21K to 359.71K | (125%) |
28-Oct-16 1:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Oct-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
28-Oct-16 1:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Oct-16 | Market Option Sale (Planned) | 6,500 | $79.26 | $515,199.00 | (2%) 366.21K to 359.71K | (120%) |
21-Oct-16 12:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Oct-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
21-Oct-16 12:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Oct-16 | Market Option Sale (Planned) | 6,500 | $81.84 | $531,976.00 | (2%) 366.21K to 359.71K | (114%) |
14-Oct-16 11:53 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Oct-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
14-Oct-16 11:53 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Oct-16 | Market Option Sale (Planned) | 6,500 | $81.14 | $527,381.00 | (2%) 366.21K to 359.71K | (115%) |
07-Oct-16 11:56 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Oct-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
07-Oct-16 11:56 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Oct-16 | Market Option Sale (Planned) | 6,500 | $87.44 | $568,379.00 | (2%) 366.21K to 359.71K | (100%) |
30-Sep-16 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 28-Sep-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
30-Sep-16 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 28-Sep-16 | Market Option Sale (Planned) | 6,500 | $88.15 | $572,978.00 | (2%) 366.21K to 359.71K | (98%) |
23-Sep-16 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Sep-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
23-Sep-16 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Sep-16 | Market Option Sale (Planned) | 6,500 | $90.82 | $590,332.00 | (2%) 366.21K to 359.71K | (92%) |
16-Sep-16 3:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Sep-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
16-Sep-16 3:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Sep-16 | Market Option Sale (Planned) | 6,500 | $92.37 | $600,387.00 | (2%) 366.21K to 359.71K | (89%) |
09-Sep-16 12:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Sep-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
09-Sep-16 12:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Sep-16 | Market Option Sale (Planned) | 6,500 | $95.66 | $621,795.00 | (2%) 366.21K to 359.71K | (83%) |
02-Sep-16 12:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Aug-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 359.71K to 366.21K | |
02-Sep-16 12:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Aug-16 | Market Option Sale (Planned) | 6,500 | $94.62 | $615,045.00 | (2%) 366.21K to 359.71K | (85%) |
26-Aug-16 1:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Aug-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 360.71K to 367.21K | |
26-Aug-16 1:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Aug-16 | Market Option Sale (Planned) | 6,500 | $100.31 | $652,032.00 | (2%) 367.21K to 360.71K | (74%) |
26-Aug-16 1:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Aug-16 | Market Sale (Planned) | 1,000 | $101.44 | $101,442.00 | (< 1%) 360.71K to 359.71K | (72%) |
24-Aug-16 12:32 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Aug-16 | Market Sale (Planned) | 1,100 | $100.79 | $110,869.00 | (< 1%) 361.81K to 360.71K | (73%) |
18-Aug-16 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Aug-16 | Option Exercise | 6,500 | $36.30 | $235,950.00 | 2% 362.21K to 368.71K |